Science Explorer Interactive view Map
Company · La Jolla · United States

Multimeric Biotherapeutics (United States)

multimericbio.comROR OpenAlex
Research works
59
▲ 157% vs 2013–17
Citations
599
10.2 per fractional work
Top-10% rate
3.8%
record average 16.5%
Open access
39%
world 28%

Not ranked overall: Multimeric Biotherapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.29× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.06× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 4.23× its world share, 1 worksImmunology and Micro…Neuroscience: 0.29× its world share, 0 worksNeuroscienceChemistry: 0.44× its world share, 0 worksChemistryEngineering: 0.41× its world share, 2 worksEngineeringMedicine: 2.57× its world share, 12 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.1×. Every wedge is a field page.

Who are the top researchers at Multimeric Biotherapeutics (United States)?

Ranked on the composite score, Heather K. Raymon lead among researchers whose main affiliation is Multimeric Biotherapeutics (United States).

  1. 1 Heather K. Raymon United States · #833,772 worldwide 56 citations · 15 works
All ranked researchers at Multimeric Biotherapeutics (United States)

Which keywords describe research at Multimeric Biotherapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Gene Therapy, Tumor Regression, Cancer Immunotherapy, AAV, Viral Vectors, Lymphoma and CAR T Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Immunotherapy6▲ 34×9 topics
  2. Gene Therapy4▲ 89×3 topics
  3. Tumor Regression4▲ 138×2 topics
  4. Cancer Immunotherapy3▲ 86×3 topics
  5. AAV3▲ 310×1 topic
  6. Lymphoma3▲ 75×2 topics
  7. Viral Vectors3▲ 310×1 topic
  8. CAR T Cells3▲ 163×1 topic
  9. Chimeric Antigen Receptor3▲ 163×1 topic
  10. Glycosylation2▲ 82×2 topics
  11. Tumor Targeting2▲ 52×2 topics
  12. Monoclonal Antibodies2▲ 94×3 topics
  13. Tumor Microenvironment2▲ 17×3 topics
  14. Therapeutic Antibodies2▲ 98×2 topics
  15. Inflammation2▲ 3.1×10 topics
  16. Antibody Engineering2▲ 116×1 topic
  17. Cancer2▲ 4.5×8 topics
  18. Fc Receptors2▲ 116×1 topic
  19. Nanoparticles2▲ 4.9×1 topic
  20. Photothermal Therapy2▲ 49×1 topic
  21. Immune Checkpoint Blockade1▲ 51×1 topic
  22. PD-1 and PD-L11▲ 51×1 topic
  23. Oxidative Stress1▲ 3.0×6 topics

Which research topics does Multimeric Biotherapeutics (United States) publish most on?

By volume in 2022–2025: Virus-based gene therapy research, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Nanoplatforms for cancer theranostics.

Virus-based gene therapy…3Virus-based gene therapy research: 3 fractional worksCAR-T cell therapy resea…3CAR-T cell therapy research: 3 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksNanoplatforms for cancer…2Nanoplatforms for cancer theranostics: 2 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksCancer Research and Treatments: 1 fractional worksViral Infectious Diseases and Gene Expression in Insects: 1 fractional worksInflammatory mediators and NSAID effects: 0 fractional worksRadiopharmaceutical Chemistry and Applications: 0 fractional worksLaser Applications in Dentistry and Medicine: 0 fractional works
GeneticsOncologyRadiology, Nuclear Medicine and ImagingBiomedical Engineering3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Virus-based gene therapy research Genetics 3 works
  2. 2 CAR-T cell therapy research Oncology 3 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 Nanoplatforms for cancer theranostics Biomedical Engineering 2 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
  6. 6 Cancer Research and Treatments Biotechnology 1 works
  7. 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  8. 8 Inflammatory mediators and NSAID effects Pharmacology 0 works
  9. 9 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Laser Applications in Dentistry and Medicine Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.7%not open61.3%

World: 28% of research is openly available.

with international co-authors21.4%domestic only78.6%

World: 19% is written across borders.

How has Multimeric Biotherapeutics (United States)'s research output changed?

Output in 2018–2022 was 157% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in La Jolla

All research institutions in La Jolla

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.